Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1987-07-01 (38 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FAMECK (57290), Moselle
PHARMACIE SAINT MARTIN - TARTARE : revenue, balance sheet and financial ratios
PHARMACIE SAINT MARTIN - TARTARE is a French company
founded 38 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FAMECK (57290),
this company of category PME
shows in 2022 a revenue of 6.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SAINT MARTIN - TARTARE (SIREN 342237880)
Indicator
2025
2024
2022
2021
2019
2018
2017
Revenue
N/C
N/C
6 486 526 €
N/C
N/C
N/C
3 823 970 €
Net income
120 982 €
-18 443 €
490 493 €
156 111 €
228 510 €
226 082 €
157 544 €
EBITDA
N/C
N/C
838 266 €
N/C
N/C
N/C
249 558 €
Net margin
N/C
N/C
7.6%
N/C
N/C
N/C
4.1%
Revenue and income statement
In 2025, PHARMACIE SAINT MARTIN - TARTARE generates positive net income of 121 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 158 k€ -> 121 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
120 982 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
27.261%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
35.145%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE SAINT MARTIN - TARTARE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2024
2025
Debt ratio
22.879
18.337
26.899
62.034
106.689
43.853
27.261
Financial autonomy
58.248
59.51
56.581
34.476
30.773
29.222
35.145
Repayment capacity
1.099
None
None
None
1.885
None
None
Cash flow / Revenue
5.681%
None%
None%
None%
10.133%
None%
None%
Sector positioning
Debt ratio
27.262025
2022
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-23 pts over 3 years
In 2025, the debt ratio of PHARMACIE SAINT MARTIN - ... (27.26) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
35.15%2025
2022
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE SAINT MARTIN - ... (35.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
1.89 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE SAINT MARTIN - ... (1.89) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 111.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
111.503
Liquidity indicators evolution PHARMACIE SAINT MARTIN - TARTARE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2024
2025
Liquidity ratio
148.552
157.429
145.2
119.357
166.907
106.984
111.503
Interest coverage
1.654
None
None
None
0.771
None
None
Sector positioning
Liquidity ratio
111.52025
2022
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch-13 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE SAINT MARTIN - ... (111.50) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
0.77x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE SAINT MARTIN - ... (0.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE SAINT MARTIN - TARTARE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2024
2025
Operating WCR
293 949 €
0 €
0 €
0 €
579 117 €
0 €
0 €
Inventory turnover (days)
35
0
0
0
37
0
0
Customer payment term (days)
4
0
0
0
7
0
0
Supplier payment term (days)
40
0
0
0
74
0
0
Positioning of PHARMACIE SAINT MARTIN - TARTARE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE SAINT MARTIN - TARTARE is estimated at
1 921 813 €
(range 1 304 151€ - 3 015 589€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1304k€1921k€3015k€
1 921 813 €Range: 1 304 151€ - 3 015 589€
NAF 5 année 2025
Valuation method used
Net Income Multiple
120 982 €
×
15.9x
=1 921 813 €
Range: 1 304 152€ - 3 015 590€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SAINT MARTIN - TARTARE with other companies in the same sector:
Frequently asked questions about PHARMACIE SAINT MARTIN - TARTARE
What is the revenue of PHARMACIE SAINT MARTIN - TARTARE ?
The revenue of PHARMACIE SAINT MARTIN - TARTARE in 2022 is 6.5 M€.
Is PHARMACIE SAINT MARTIN - TARTARE profitable?
Yes, PHARMACIE SAINT MARTIN - TARTARE generated a net profit of 121 k€ in 2025.
Where is the headquarters of PHARMACIE SAINT MARTIN - TARTARE ?
The headquarters of PHARMACIE SAINT MARTIN - TARTARE is located in FAMECK (57290), in the department Moselle.
Where to find the tax return of PHARMACIE SAINT MARTIN - TARTARE ?
The tax return of PHARMACIE SAINT MARTIN - TARTARE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SAINT MARTIN - TARTARE operate?
PHARMACIE SAINT MARTIN - TARTARE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart